|Last Price||Today's Change||52-Week Range||Trading Volume|
|53.12||0.00 (0.00%)||45.45 - 71.60||150.0 (Below Avg)|
Market data as of 12:00AM 02/05/16. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb and AbbVie Receive Positive CHMP Opinion for Investigational Antibody, Empliciti (elotuzumab), for the Treatment of Multiple Myeloma in Patients Who Have Received at Least One Prior Therapy
01/29/2016 7:48 AM ET
AbbVie Reports Full-Year 2015 and Fourth-Quarter Financial Results
01/29/2016 7:47 AM ET